The United States Food and Drug Administration has just approved the first-ever clinical trial that uses CRISPR-Cas13 RNA ...

Lorati Company Limited has introduced a groundbreaking advancement in the treatment of age-related macular degeneration (AMD), including both dry and wet forms, with its nano-grade eye drops. Mr.

Eye diseases like glaucoma, cataracts, and conjunctivitis are some of the more common types. Find eye disease awareness and ...

The California Institute for Regenerative Medicine (CIRM), the state's stem cell agency, has awarded a two-year, $6 million ...

Few pharmaceutical products have taken the market by storm like Roche’s Vabysmo. | Interim results from a late-stage trial of ...

At Beilinson Hospital, we are committed to tackling this issue head-on by embracing the technological revolution in eye care.

The California Institute for Regenerative Medicine has funded Keck School of Medicine of USC translational research advancing ...

A retrospective review of home-based optical coherence tomography (OCT) monitoring for neovascular age-related macular ...

Opthea (ASX/NASDAQ:OPT) is a biopharmaceutical company developing novel therapies to address the unmet needs in the treatment of highly prevalent and progressive retinal diseases, including wet ...

Adverum Biotechnologies advances wet AMD treatment with promising trial results. See why ADVM stock has potential as it ...

Findings from a post hoc analysis of the AREDS and AREDS2 studies were presented at the recent American Academy of ...

Wet Age-Related Macular Degeneration, a grave ocular ailment, is marked by the development of abnormal blood vessels beneath the retina leading to vision impairment. The disease's multifactorial ...